QuiVad

Home / Japan / Nxera Pharma Co.,Ltd.

Nxera Pharma Co.,Ltd.

Short position disclosed on August 10, 2026.

Follow

Evolution of the disclosed total

0%2%4%6%
Aug 5Aug 7Aug 9Aug 11Aug 13
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
UBS AG0.79%newAugust 10, 2026

History of disclosures

12 disclosures on record for this share.
DateFund% of capitalEnd of publication
August 10, 2026UBS AG0.79%still open
August 7, 2026Goldman Sachs International1.69%still open
August 7, 2026Citigroup Global Markets Limited1.11%still open
August 7, 2026Barclays Capital Securities Ltd1.09%still open
August 7, 2026UBS AG0.68%still open
August 6, 2026Goldman Sachs International1.56%still open
August 6, 2026Barclays Capital Securities Ltd1.11%still open
August 6, 2026UBS AG0.79%still open
August 5, 2026Goldman Sachs International1.60%still open
August 5, 2026Barclays Capital Securities Ltd1.09%still open
August 3, 2026Citigroup Global Markets Limited1.00%still open
August 3, 2026Barclays Capital Securities Ltd0.95%still open

Other companies sold short in Japan

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Nxera Pharma Co.,Ltd., source JPX, data as at August 10, 2026, https://www.quivad.com/action/nxera-pharma-co-ltd